Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- befree-2016 importedOn "2016-02-19" NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_assertion wasGeneratedBy ECO_0000203 NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_assertion wasDerivedFrom befree-2016 NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_assertion SIO_000772 12669679 NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_assertion evidence source_evidence_literature NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.
- NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_assertion description "[These criteria identify targets for therapy designed to normalize expression of PAI-1 and retard progression of atherosclerosis in subjects with elevated concentrations of FFA in blood including those with insulin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389249.RAfQBGoQEw9X8M5rtmP8LvRHhqR7CSjXZkrpvky-GXeMw130_provenance.